The UniCel DxI 600 Access Immunoassay System helps laboratories running 40,000-80,000 tests per year meet peak workload demands with throughput of up to 200 tests per hour and up to …

Accelerate immunoassay time-to-results in your high-volume lab with the UniCel DxI 800 Access Immunoassay System. Run up to 400 tests per hour and handle even the most demanding workloads with ease.

The DxI 9000 analyzer’s industry-leading high throughput (up to 450 tests per hour), optimized reagent consumption, and improved yields and traceability accelerate answers and amplify productivity.

Accelerate immunoassay time-to-results in your high-volume lab with the UniCel DxI 800 Access Immunoassay System. Run up to 400 tests per hour and handle even the most demanding workloads with ease. Count on the DxI 800 to be ready when you are, with low maintenance and improved reliability.

Barcelona, April 16, 2024 — Beckman Coulter Diagnostics, a leader in clinical diagnostics, announced today, ahead of the congress of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID Global), that it has extended the menu of DxI 9000 Immunoassay Analyzer * assays.

Beckman Coulter’s DxI 9000 Access Immunoassay Analyzer is designed to achieve faster throughput, employ an enhanced chemiluminescent substrate (Lumi-Phos PRO), deliver shorter turnaround times, run more tests per reagent pack, and provide improved user workflows, when compared to the legacy Access UniCel DxI 800 Immunoassay System.

Fast throughput for demanding workloads meet the throughput needs of any mid- or high-volume laboratory. Whether it is the DxI 600, that can run up to 200 tests per hour, or the high-speed DxI 800, with a maximum throughput of 400 tests per hour, each DxI analyzer uses the same proven chemiluminescent

ANAHEIM, CALIF., July 25, 2023 — Beckman Coulter, a clinical diagnostics leader, today revealed for the first time in North America the DxI 9000 Access Immunoassay Analyzer, addressing clinical laboratory demands for speed, reliability, reproducibility, quality, …

Beckman Coulter’s N-terminal pro b-type natriuretic peptide (NT-proBNP) assay is now available on the DxI 9000 Immunoassay Analyzer for detection of heart failure and cardiac dysfunction biomarkers in line with both European Society of Cardiology guidelines and the American College of Cardiology/American Heart Association guidelines.

Bring scalability, reliability and simplicity to your immunoassay testing. Find an immunoassay analyzer, assays or instrument tailored to your lab.